Navigating Patient Consent Scenarios In COVID-19 Trials
Source: IQVIA Technologies
By Karen Maduschke, Sr. Director & General Manager, eConsent, IQVIA Technologies
In his recent blog, my colleague Eric Delente shared the most frequently asked questions that IQVIA Technologies is being asked during the COVID-19 crisis. Many found the article helpful and had further questions around the topic of remote consent in a hospital setting, particularly when the patient is quite ill and requires a legally acceptable representative (LAR) to consent on his or her behalf. Thus, I’d like to share further insights on this topic as we gain experience through real-life implementations around the world.
VIEW THE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader